Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid

Histopathology

Volumn 48, Issue 7, 2006, Pages 795-800

  Rossi, E D ^a   Raffaelli, M ^a   Mule', A ^a   Miraglia, A ^a   Lombardi, C P ^a   Vecchio, F M ^a   Fadda, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Hyperfunctioning lesions; Immunohistochemistry; Thyroid neoplasms

Indexed keywords

ANTIBODY; CYTOKERATIN 19; GALECTIN 3;

ARTICLE; CANCER DIAGNOSIS; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID NODULE;

CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; GALECTIN 3; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KERATINS; PROTO-ONCOGENE PROTEINS C-RET; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33744456468     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2006.02428.x     Document Type: Article

References (21)

1. LiVolsi VA. Surgical pathology of the thyroid. Major Problems in Pathology, Vol. 5. Philadelphia : W. B. Saunders 1990.
2. Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland. Atlas of tumor pathology, 3rd series, Fascicle 5. Washington, DC : Armed Forces Institute of Pathology 1992.
3. Baloch ZW, LiVolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am. J. Clin. Pathol. 2002 117 143 150.
4. Lloyd RV, Khan A, Nose' V. Pathology of the thyroid gland. Endocrine pathology. Differential diagnosis and molecular advances. Totowa, NJ : Humana Press 2004 153 189.
5. Hapke MR, Dehner LP. The optically clear nucleus. A reliable sign of papillary carcinoma of the thyroid. Am. J. Surg. Pathol. 1979 3 31 38.
6. Miettinen M, Karkkainen P. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours. Virchows Arch. 1996 429 213 219.
7. Sack MJ, Astengo-Osuna C, Lin BT, Battifora H, LiVolsi VA. HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Mod. Pathol. 1997 10 668 674.
8. Cheung C, Ezzat S, Freeman JL, Rosen IB, Asa S. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod. Pathol. 2001 14 338 342.
9. Miettinen M, Kovatich AJ, Karkkainen P. Keratin subsets in papillary and follicular thyroid lesions. A paraffin section analysis with diagnostic implications. Virchows Arch. 1997 431 407 413.
10. Baloch ZW, Abraham S, Roberts S, LiVolsi VA. Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility. Hum. Pathol. 1999 30 1166 1171.
11. Rossi ED, Raffaelli M, Minimo C et al. Immunocytochemical evaluation of thyroid neoplasms on thin-layer smears from fine-needle aspiration biopsies. Cancer 2005 105 87 95.
12. Saggiorato E, Cappia S, De Giuli P et al. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J. Clin. Endocrinol. Metab. 2001 86 5152 5158.
13. Yamamoto Y, Izumi K, Tsuka H. An immunohistochemical study of epithelial membrane antigen, cytokeratin and vimentin in papillary thyroid carcinoma. Recognition of lethal and favourable prognostic types. Cancer 1992 70 2326 2333.
14. Khurana KK, Truong LD, LiVolsi VA, Baloch ZW. Cytokeratin 19 immunolocalization in cell block preparation of thyroid aspirates. An adjunct to fine-needle aspiration diagnosis of papillary thyroid carcinoma. Arch. Pathol. Lab. Med. 2003 127 579 583.
15. Casey MB, Lohse CM, Lloyd RV. Distinction between papillary thyroid hyperplasia and papillary carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3 and HBME-1. Endocr. Pathol. 2003 14 55 60.
16. Finley DJ, Arora N, Zhu B, Gallagher L, Fahey TJ. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules. J. Clin. Endocrinol. Metab. 2004 89 3214 3223.
17. Prasad ML, Pellegata NS, Huang Y, Nagaraja HN, De La Chapelle A, Kloos RT. Galectin-3, fibronectin-1, CITED-1, HBME-1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod. Pathol. 2004 78 48 57.
18. Albores-Saavedra J, Gould E, Vardaman C, Vuitch F. The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases. Hum. Pathol. 1991 22 1195 1120.
19. Baloch ZW, Gupta PK, Yu GH, Sack MJ, LiVolsi VA. Follicular variant of papillary carcinoma. Cytologic and histologic correlation. Am. J. Clin. Pathol. 1999 111 216 222.
20. Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Nikiforov YE. PAX8-PPARy rearrangement in thyroid tumors. RT-PCR and immunohistochemical analyses. Am. J. Surg. Pathol. 2002 26 1016 1023.
21. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001 357 1644 1650.